A Study of Avoralstat In Participants With Diabetic Macular Edema

Clinical trial NCT07228559 · TERMINATED

Trial details

NCT number: NCT07228559
Sponsor: BioCryst Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Macular Edema (DME)

Start date: 2025-10-02
Primary completion: 2026-04-17
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.